Immutep (IMMP) Accumulated Expenses (2016 - 2025)
Immutep's (IMMP) quarterly Accumulated Expenses came in at $6.7 million in Q4 2025, up 298.34% YoY from $1.7 million in Q4 2024, and up 125.82% on a QoQ basis from $3.0 million in Q2 2025.
Immutep (IMMP) Accumulated Expenses (2016 - 2025) Analysis & Trends
Immutep (IMMP) has 10 years of Accumulated Expenses data on file, last reported at $6.7 million in Q4 2025.
- Quarterly Accumulated Expenses rose 298.34% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (up 298.34% YoY) and the FY2025 annual result came in at $3.0 million, up 554.92% from the prior year.
- Accumulated Expenses grew to $6.7 million in Q4 2025, from $3.0 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $6.7 million in Q4 2025 to a low of $42.98 in Q4 2021.
- A 5-year average of $1.6 million and a median of $415460.5 in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Accumulated Expenses sank 98.61% — and 2025, when it surged 554.92%.
- Tracing IMMP's Accumulated Expenses over 5 years: stood at $42.98 in 2021, then surged by 594872.97% to $255728.6 in 2022, then soared by 46.96% to $375819.7 in 2023, then jumped by 349.6% to $1.7 million in 2024, then jumped by 298.34% to $6.7 million in 2025.
- The last three Accumulated Expenses figures came in at $6.7 million (Q4 2025), $3.0 million (Q2 2025), and $1.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.73 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Jun 30, 2024 | 455,101.22 |
| Jun 30, 2023 | 375,819.75 |
| Jun 30, 2022 | 255,728.56 |
| Dec 31, 2021 | 42.98 |
| Jun 30, 2021 | 269,623.26 |
| Dec 31, 2020 | 3,087.47 |
| Jun 30, 2020 | 196,931.61 |
| Dec 31, 2019 | 9,883.01 |
| Jun 30, 2019 | 167,111.67 |
| Jun 30, 2018 | 143,469.09 |
| Jun 30, 2017 | 32,472.57 |
| Mar 31, 2017 | 73.48 |
| Jun 30, 2016 | 152.33 |